Biogen Phase III choroideremia study did not meet primary endpoint
June 15, 2021Manufacturing and Production Biogen, choroideremia, phase III
Biogen has announced that its investigational gene therapy study for the potential treatment of choroideremia did not meet its primary …
Bone regeneration stem cell “putty” sees positive results in trials
June 15, 2021Manufacturing and Production Cell regeneration, Stem cells, bone, platform, technology
Belgian clinical stage company, Novadip Biosciences, has announced positive results from its Phase I trial of its autologous cell-based osteogenic …
Cognito Therapeutics initiates Down syndrome Alzheimer’s study
June 15, 2021Manufacturing and Production
Cognito Therapeutics are going to run a second digital therapeutic study evaluating individuals who have the genetic rare disease, Down …
Janssen CLL treatment combination sees success in trials
June 14, 2021Sales and Marketing CLL, Janssen
Janssen has announced positive data from its Phase III GLOW study, with the combination of imbruvica (ibrutinib) plus venetoclax (I+V) …
EMA official recommends avoiding AstraZeneca vaccine
June 14, 2021Sales and Marketing
A senior executive at the EMA recommended abandoning the use of the AstraZeneca vaccine in the EU where alternatives are …
NICE recommends treatments for rare form of colorectal cancer
June 14, 2021Sales and Marketing
NICE has recommended BMS’s nivolumab plus ipilimumab (also known as Opdivo and Yervoy) to treat people with a rare form …
Experimental COVID antibody treatment successful in trials
June 14, 2021Sales and Marketing COVID-19, antibody therapy, celltrion, phase III
Celltrion has announced positive top-line data for its experimental antibody COVID-19 treatment, with Phase III trials finding it safe and …
Germany demands that J&J replace contaminated vaccine doses
June 14, 2021Sales and Marketing
Germany’s health ministry has demanded that J&J must deliver 6.5 million COVID-19 vaccine doses to Germany in July to make …
Third FDA panel member quits over controversial Alzheimer’s drug approval
June 11, 2021Medical Communications
The third FDA advisory panel member has quit over the approval of a controversial new Alzheimer’s drug. Biogen’s drug, aducanumab, …
“The future of pain care”: Virtual reality therapy proven to aid chronic pain
June 11, 2021Medical Communications CBT, Virtual reality, chronic pain management, technology
A novel digital therapeutics software, DTxP, has shown statistically significant benefits for patients with chronic low back pain (CLBP) in …
G7: UK to donate 100 million surplus vaccine doses
June 11, 2021Medical Communications Boris Johnson, COVID-19, G7, Joe Biden, UK, US, Vaccine
Boris Johnson has announced at the G7 meeting in Cornwall that the UK will donate over 100 million surplus doses …
Sutimlimab meets primary endpoint in treating cold agglutinin disease
June 11, 2021Medical Communications
A Phase III study evaluating the safety and efficacy of sutimlimab in people with cold agglutinin disease (CAD) met its …
Pharmafile.com’s top 10 news stories of the week
June 11, 2021Medical Communications
Among our ten most-read stories this week: AstraZeneca vs GSK: Cancer drug court battle could cost hundreds of millions; New …
Phase III breast cancer trial meets primary endpoint
June 10, 2021Byondis has revealed positive Phase III results for (ADC) [vic-]trastuzumab duocarmazine (SYD985) in patients with HER2-positive unresectable locally advanced or …
Pharmafile.com’s weekly COVID-19 news round-up
June 10, 2021The past week has seen lots of vaccine-related news, Pfizer-BioNTech has expanded its COVID-19 vaccine study in children under 12, …
NICE release new guidance on rheumatoid arthritis treatment
June 10, 2021NICE, biosimilar, rheumatoid arthritis
NICE has today published final draft guidance for the treatment of moderate rheumatoid arthritis in patients who have not responded …
SMC approves nintedanib for patients with chronic lung disease
June 10, 2021The Scottish Medicines Consortium (SMC) has approved nintedanib for NHSScotland for the treatment of adult patients with chronic fibrosing interstitial …
COVID chaos: Survey reveals global oncology trial disruptions
June 10, 2021data, oncology
The pandemic has had a widespread impact across the healthcare industry and the world, however, a recent global survey from …
Pfizer to expand COVID vaccine study in children under 12
June 10, 2021COVID-19, Pfizer, Vaccine
Pfizer has announced that it will begin large-scale testing of its COVID-19 vaccine after selecting a lower dose of the …
Phase III trial supports the potential use of Cabometyx for thyroid cancer
June 8, 2021Manufacturing and Production
Ipsen and Exelixis have announced detailed results from the Phase III COSMIC-311 pivotal trial of Cabozantinib in patients with previously …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
